1 Pirfenidone Market Overview 1.1 Pirfenidone Product Overview 1.2 Pirfenidone Market Segment by Type 1.2.1 Tablet 1.2.2 Capsule 1.2.3 Other 1.3 Global Pirfenidone Market Size by Type 1.3.1 Global Pirfenidone Market Size Overview by Type (2016-2027) 1.3.2 Global Pirfenidone Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Pirfenidone Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Pirfenidone Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Pirfenidone Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Pirfenidone Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Pirfenidone Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Pirfenidone Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Pirfenidone Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Pirfenidone Sales Breakdown by Type (2016-2021) 1.4.2 Europe Pirfenidone Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Pirfenidone Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Pirfenidone Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Pirfenidone Sales Breakdown by Type (2016-2021) 2 Global Pirfenidone Market Competition by Company 2.1 Global Top Players by Pirfenidone Sales (2016-2021) 2.2 Global Top Players by Pirfenidone Revenue (2016-2021) 2.3 Global Top Players Pirfenidone Price (2016-2021) 2.4 Global Top Manufacturers Pirfenidone Manufacturing Base Distribution, Sales Area, Product Type 2.5 Pirfenidone Market Competitive Situation and Trends 2.5.1 Pirfenidone Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Pirfenidone Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pirfenidone as of 2020) 2.7 Date of Key Manufacturers Enter into Pirfenidone Market 2.8 Key Manufacturers Pirfenidone Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Pirfenidone Status and Outlook by Region 3.1 Global Pirfenidone Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Pirfenidone Historic Market Size by Region 3.2.1 Global Pirfenidone Sales in Volume by Region (2016-2021) 3.2.2 Global Pirfenidone Sales in Value by Region (2016-2021) 3.2.3 Global Pirfenidone Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Pirfenidone Forecasted Market Size by Region 3.3.1 Global Pirfenidone Sales in Volume by Region (2022-2027) 3.3.2 Global Pirfenidone Sales in Value by Region (2022-2027) 3.3.3 Global Pirfenidone Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Pirfenidone by Application 4.1 Pirfenidone Market Segment by Application 4.1.1 Mild Idiopathic Pulmonary Fibrosis 4.1.2 Moderate Idiopathic Pulmonary Fibrosis 4.1.3 Other 4.2 Global Pirfenidone Market Size by Application 4.2.1 Global Pirfenidone Market Size Overview by Application (2016-2027) 4.2.2 Global Pirfenidone Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Pirfenidone Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Pirfenidone Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Pirfenidone Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Pirfenidone Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Pirfenidone Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Pirfenidone Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Pirfenidone Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Pirfenidone Sales Breakdown by Application (2016-2021) 4.3.2 Europe Pirfenidone Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Pirfenidone Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Pirfenidone Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Pirfenidone Sales Breakdown by Application (2016-2021) 5 North America Pirfenidone by Country 5.1 North America Pirfenidone Historic Market Size by Country 5.1.1 North America Pirfenidone Sales in Volume by Country (2016-2021) 5.1.2 North America Pirfenidone Sales in Value by Country (2016-2021) 5.2 North America Pirfenidone Forecasted Market Size by Country 5.2.1 North America Pirfenidone Sales in Volume by Country (2022-2027) 5.2.2 North America Pirfenidone Sales in Value by Country (2022-2027) 6 Europe Pirfenidone by Country 6.1 Europe Pirfenidone Historic Market Size by Country 6.1.1 Europe Pirfenidone Sales in Volume by Country (2016-2021) 6.1.2 Europe Pirfenidone Sales in Value by Country (2016-2021) 6.2 Europe Pirfenidone Forecasted Market Size by Country 6.2.1 Europe Pirfenidone Sales in Volume by Country (2022-2027) 6.2.2 Europe Pirfenidone Sales in Value by Country (2022-2027) 7 Asia-Pacific Pirfenidone by Region 7.1 Asia-Pacific Pirfenidone Historic Market Size by Region 7.1.1 Asia-Pacific Pirfenidone Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Pirfenidone Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Pirfenidone Forecasted Market Size by Region 7.2.1 Asia-Pacific Pirfenidone Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Pirfenidone Sales in Value by Region (2022-2027) 8 Latin America Pirfenidone by Country 8.1 Latin America Pirfenidone Historic Market Size by Country 8.1.1 Latin America Pirfenidone Sales in Volume by Country (2016-2021) 8.1.2 Latin America Pirfenidone Sales in Value by Country (2016-2021) 8.2 Latin America Pirfenidone Forecasted Market Size by Country 8.2.1 Latin America Pirfenidone Sales in Volume by Country (2022-2027) 8.2.2 Latin America Pirfenidone Sales in Value by Country (2022-2027) 9 Middle East and Africa Pirfenidone by Country 9.1 Middle East and Africa Pirfenidone Historic Market Size by Country 9.1.1 Middle East and Africa Pirfenidone Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Pirfenidone Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Pirfenidone Forecasted Market Size by Country 9.2.1 Middle East and Africa Pirfenidone Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Pirfenidone Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Pirfenidone Business 10.1 Genentech (Roche) 10.1.1 Genentech (Roche) Corporation Information 10.1.2 Genentech (Roche) Introduction and Business Overview 10.1.3 Genentech (Roche) Pirfenidone Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Genentech (Roche) Pirfenidone Products Offered 10.1.5 Genentech (Roche) Recent Development 10.2 Shionogi 10.2.1 Shionogi Corporation Information 10.2.2 Shionogi Introduction and Business Overview 10.2.3 Shionogi Pirfenidone Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Genentech (Roche) Pirfenidone Products Offered 10.2.5 Shionogi Recent Development 10.3 GNI Group 10.3.1 GNI Group Corporation Information 10.3.2 GNI Group Introduction and Business Overview 10.3.3 GNI Group Pirfenidone Sales, Revenue and Gross Margin (2016-2021) 10.3.4 GNI Group Pirfenidone Products Offered 10.3.5 GNI Group Recent Development 10.4 Beijing Continent 10.4.1 Beijing Continent Corporation Information 10.4.2 Beijing Continent Introduction and Business Overview 10.4.3 Beijing Continent Pirfenidone Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Beijing Continent Pirfenidone Products Offered 10.4.5 Beijing Continent Recent Development 10.5 Cipla 10.5.1 Cipla Corporation Information 10.5.2 Cipla Introduction and Business Overview 10.5.3 Cipla Pirfenidone Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Cipla Pirfenidone Products Offered 10.5.5 Cipla Recent Development 10.6 Lupin Ltd 10.6.1 Lupin Ltd Corporation Information 10.6.2 Lupin Ltd Introduction and Business Overview 10.6.3 Lupin Ltd Pirfenidone Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Lupin Ltd Pirfenidone Products Offered 10.6.5 Lupin Ltd Recent Development 10.7 Zydus Cadila 10.7.1 Zydus Cadila Corporation Information 10.7.2 Zydus Cadila Introduction and Business Overview 10.7.3 Zydus Cadila Pirfenidone Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Zydus Cadila Pirfenidone Products Offered 10.7.5 Zydus Cadila Recent Development 10.8 Glenmark Pharmaceuticals 10.8.1 Glenmark Pharmaceuticals Corporation Information 10.8.2 Glenmark Pharmaceuticals Introduction and Business Overview 10.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Glenmark Pharmaceuticals Pirfenidone Products Offered 10.8.5 Glenmark Pharmaceuticals Recent Development 10.9 Koye Pharmaceuticals 10.9.1 Koye Pharmaceuticals Corporation Information 10.9.2 Koye Pharmaceuticals Introduction and Business Overview 10.9.3 Koye Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2016-2021) 10.9.4 Koye Pharmaceuticals Pirfenidone Products Offered 10.9.5 Koye Pharmaceuticals Recent Development 10.10 MSN Laboratories 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Pirfenidone Product Category, Application and Specification 10.10.3 MSN Laboratories Pirfenidone Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 MSN Laboratories Recent Development 10.11 Wockhardt 10.11.1 Wockhardt Corporation Information 10.11.2 Wockhardt Introduction and Business Overview 10.11.3 Wockhardt Pirfenidone Sales, Revenue and Gross Margin (2016-2021) 10.11.4 Wockhardt Pirfenidone Products Offered 10.11.5 Wockhardt Recent Development 10.12 Incepta Pharmaceuticals 10.12.1 Incepta Pharmaceuticals Corporation Information 10.12.2 Incepta Pharmaceuticals Introduction and Business Overview 10.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2016-2021) 10.12.4 Incepta Pharmaceuticals Pirfenidone Products Offered 10.12.5 Incepta Pharmaceuticals Recent Development 10.13 Unimed Unihealth 10.13.1 Unimed Unihealth Corporation Information 10.13.2 Unimed Unihealth Introduction and Business Overview 10.13.3 Unimed Unihealth Pirfenidone Sales, Revenue and Gross Margin (2016-2021) 10.13.4 Unimed Unihealth Pirfenidone Products Offered 10.13.5 Unimed Unihealth Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Pirfenidone Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Pirfenidone Industrial Chain Analysis 11.4 Pirfenidone Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Pirfenidone Distributors 12.3 Pirfenidone Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Capsule Table 3. Major Company of Other Table 4. Global Pirfenidone Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Pirfenidone Sales by Type (2016-2021) & (K Pcs) Table 6. Global Pirfenidone Sales Market Share in Volume by Type (2016-2021) Table 7. Global Pirfenidone Sales by Type (2016-2021) & (US& Million) Table 8. Global Pirfenidone Market Share in Value by Type (2016-2021) Table 9. Global Pirfenidone Price by Type (2016-2021) & (USD/Pcs) Table 10. Global Pirfenidone Sales by Type (2022-2027) & (K Pcs) Table 11. Global Pirfenidone Sales Market Share in Volume by Type (2022-2027) Table 12. Global Pirfenidone Sales by Type (2022-2027) & (US$ Million) Table 13. Global Pirfenidone Sales Market Share in Value by Type (2022-2027) Table 14. Global Pirfenidone Price by Type (2022-2027) & (USD/Pcs) Table 15. North America Pirfenidone Sales by Type (2016-2021) & (K Pcs) Table 16. North America Pirfenidone Sales by Type (2016-2021) & (US$ Million) Table 17. Europe Pirfenidone Sales (K Pcs) by Type (2016-2021) Table 18. Europe Pirfenidone Sales by Type (2016-2021) & (US$ Million) Table 19. Asia-Pacific Pirfenidone Sales (K Pcs) by Type (2016-2021) Table 20. Asia-Pacific Pirfenidone Sales by Type (2016-2021) & (US$ Million) Table 21. Latin America Pirfenidone Sales (K Pcs) by Type (2016-2021) Table 22. Latin America Pirfenidone Sales by Type (2016-2021) & (US$ Million) Table 23. Middle East and Africa Pirfenidone Sales (K Pcs) by Type (2016-2021) Table 24. Middle East and Africa Pirfenidone Sales by Type (2016-2021) & (US$ Million) Table 25. Global Pirfenidone Sales by Company (2016-2021) & (K Pcs) Table 26. Global Pirfenidone Sales Share by Company (2016-2021) Table 27. Global Pirfenidone Revenue by Company (2016-2021) & (US$ Million) Table 28. Global Pirfenidone Revenue Share by Company (2016-2021) Table 29. Global Market Pirfenidone Price by Company (2016-2021) & (USD/Pcs) Table 30. Global Pirfenidone Top Manufacturers Manufacturing Base Distribution and Sales Area Table 31. Global Pirfenidone Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pirfenidone as of 2020 Table 33. Date of Key Manufacturers Enter into Pirfenidone Market Table 34. Key Manufacturers Pirfenidone Product Type Table 35. Mergers & Acquisitions, Expansion Plans Table 36. Global Pirfenidone Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 37. Global Pirfenidone Sales by Region (2016-2021) & (K Pcs) Table 38. Global Pirfenidone Sales Market Share in Volume by Region (2016-2021) Table 39. Global Pirfenidone Sales by Region (2016-2021) & (US$ Million) Table 40. Global Pirfenidone Sales Market Share in Value by Region (2016-2021) Table 41. Global Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 42. Global Pirfenidone Sales by Region (2022-2027) & (K Pcs) Table 43. Global Pirfenidone Sales Market Share in Volume by Region (2022-2027) Table 44. Global Pirfenidone Sales by Region (2022-2027) & (US$ Million) Table 45. Global Pirfenidone Sales Market Share in Value by Region (2022-2027) Table 46. Global Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 47. Global Pirfenidone Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 48. Global Pirfenidone Sales by Application (2016-2021) & (K Pcs) Table 49. Global Pirfenidone Sales Market Share in Volume by Application (2016-2021) Table 50. Global Pirfenidone Sales by Application (2016-2021) & (US$ Million) Table 51. Global Pirfenidone Sales Market Share in Value by Application (2016-2021) Table 52. Global Pirfenidone Price by Application (2016-2021) & (USD/Pcs) Table 53. Global Pirfenidone Sales by Application (2022-2027) & (K Pcs) Table 54. Global Pirfenidone Sales Market Share in Volume by Application (2022-2027) Table 55. Global Pirfenidone Sales by Application (2022-2027) & (US$ Million) Table 56. Global Pirfenidone Sales Market Share in Value by Application (2022-2027) Table 57. Global Pirfenidone Price by Application (2022-2027) & (USD/Pcs) Table 58. North America Pirfenidone Sales by Application (2016-2021) (K Pcs) Table 59. North America Pirfenidone Sales by Application (2016-2021) & (US$ Million) Table 60. North America Pirfenidone Sales Market Share in Value by Application in 2020 Table 61. Europe Pirfenidone Sales by Application (2016-2021) (K Pcs) Table 62. Europe Pirfenidone Sales by Application (2016-2021) & (US$ Million) Table 63. Europe Pirfenidone Sales Market Share in Value by Application in 2020 Table 64. Asia-Pacific Pirfenidone Sales by Application (2016-2021) (K Pcs) Table 65. Asia-Pacific Pirfenidone Sales by Application (2016-2021) & (US$ Million) Table 66. Asia-Pacific Pirfenidone Sales Market Share in Value by Application in 2020 Table 67. Latin America Pirfenidone Sales by Application (2016-2021) (K Pcs) Table 68. Latin America Pirfenidone Sales by Application (2016-2021) & (US$ Million) Table 69. Latin America Pirfenidone Sales Market Share in Value by Application in 2020 Table 70. Middle East and Africa Pirfenidone Sales by Application (2016-2021) (K Pcs) Table 71. Middle East and Africa Pirfenidone Sales by Application (2016-2021) & (US$ Million) Table 72. Middle East and Africa Pirfenidone Sales Market Share in Value by Application in 2020 Table 73. North America Pirfenidone Sales by Country (2016-2021) & (K Pcs) Table 74. North America Pirfenidone Sales Market Share in Volume by Country (2016-2021) Table 75. North America Pirfenidone Sales by Country (2016-2021) & (US$ Million) Table 76. North America Pirfenidone Sales Market Share in Value by Country (2016-2021) Table 77. North America Pirfenidone Sales by Country (2022-2027) & (K Pcs) Table 78. North America Pirfenidone Sales Market Share in Volume by Country (2022-2027) Table 79. North America Pirfenidone Sales by Country (2022-2027) & (US$ Million) Table 80. North America Pirfenidone Sales Market Share in Value by Country (2022-2027) Table 81. Europe Pirfenidone Sales by Country (2016-2021) & (K Pcs) Table 82. Europe Pirfenidone Sales Market Share in Volume by Country (2016-2021) Table 83. Europe Pirfenidone Sales by Country (2016-2021) & (US$ Million) Table 84. Europe Pirfenidone Sales Market Share in Value by Country (2016-2021) Table 85. Europe Pirfenidone Sales by Country (2022-2027) & (K Pcs) Table 86. Europe Pirfenidone Sales Market Share in Volume by Country (2022-2027) Table 87. Europe Pirfenidone Sales by Country (2022-2027) & (US$ Million) Table 88. Europe Pirfenidone Sales Market Share in Value by Country (2022-2027) Table 89. Asia-Pacific Pirfenidone Sales by Region (2016-2021) & (K Pcs) Table 90. Asia-Pacific Pirfenidone Sales Market Share in Volume by Region (2016-2021) Table 91. Asia-Pacific Pirfenidone Sales by Region (2016-2021) & (US$ Million) Table 92. Asia-Pacific Pirfenidone Sales Market Share in Value by Region (2016-2021) Table 93. Asia-Pacific Pirfenidone Sales by Region (2022-2027) & (K Pcs) Table 94. Asia-Pacific Pirfenidone Sales Market Share in Volume by Region (2022-2027) Table 95. Asia-Pacific Pirfenidone Sales by Region (2022-2027) & (US$ Million) Table 96. Asia-Pacific Pirfenidone Sales Market Share in Value by Region (2022-2027) Table 97. Latin America Pirfenidone Sales by Country (2016-2021) & (K Pcs) Table 98. Latin America Pirfenidone Sales Market Share in Volume by Country (2016-2021) Table 99. Latin America Pirfenidone Sales by Country (2016-2021) & (US$ Million) Table 100. Latin America Pirfenidone Sales Market Share in Value by Country (2016-2021) Table 101. Latin America Pirfenidone Sales by Country (2022-2027) & (K Pcs) Table 102. Latin America Pirfenidone Sales Market Share in Volume by Country (2022-2027) Table 103. Latin America Pirfenidone Sales by Country (2022-2027) & (US$ Million) Table 104. Latin America Pirfenidone Sales Market Share in Value by Country (2022-2027) Table 105. Middle East and Africa Pirfenidone Sales by Country (2016-2021) & (K Pcs) Table 106. Middle East and Africa Pirfenidone Sales Market Share in Volume by Country (2016-2021) Table 107. Middle East and Africa Pirfenidone Sales by Country (2016-2021) & (US$ Million) Table 108. Middle East and Africa Pirfenidone Sales Market Share in Value by Country (2016-2021) Table 109. Middle East and Africa Pirfenidone Sales by Country (2022-2027) & (K Pcs) Table 110. Middle East and Africa Pirfenidone Sales Market Share in Volume by Country (2022-2027) Table 111. Middle East and Africa Pirfenidone Sales by Country (2022-2027) & (US$ Million) Table 112. Middle East and Africa Pirfenidone Sales Market Share in Value by Country (2022-2027) Table 113. Genentech (Roche) Corporation Information Table 114. Genentech (Roche) Introduction and Business Overview Table 115. Genentech (Roche) Pirfenidone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 116. Genentech (Roche) Pirfenidone Product Table 117. Genentech (Roche) Recent Development Table 118. Shionogi Corporation Information Table 119. Shionogi Introduction and Business Overview Table 120. Shionogi Pirfenidone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 121. Shionogi Pirfenidone Product Table 122. Shionogi Recent Development Table 123. GNI Group Corporation Information Table 124. GNI Group Introduction and Business Overview Table 125. GNI Group Pirfenidone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 126. GNI Group Pirfenidone Product Table 127. GNI Group Recent Development Table 128. Beijing Continent Corporation Information Table 129. Beijing Continent Introduction and Business Overview Table 130. Beijing Continent Pirfenidone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 131. Beijing Continent Pirfenidone Product Table 132. Beijing Continent Recent Development Table 133. Cipla Corporation Information Table 134. Cipla Introduction and Business Overview Table 135. Cipla Pirfenidone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 136. Cipla Pirfenidone Product Table 137. Cipla Recent Development Table 138. Lupin Ltd Corporation Information Table 139. Lupin Ltd Introduction and Business Overview Table 140. Lupin Ltd Pirfenidone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 141. Lupin Ltd Pirfenidone Product Table 142. Lupin Ltd Recent Development Table 143. Zydus Cadila Corporation Information Table 144. Zydus Cadila Introduction and Business Overview Table 145. Zydus Cadila Pirfenidone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 146. Zydus Cadila Pirfenidone Product Table 147. Zydus Cadila Recent Development Table 148. Glenmark Pharmaceuticals Corporation Information Table 149. Glenmark Pharmaceuticals Introduction and Business Overview Table 150. Glenmark Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 151. Glenmark Pharmaceuticals Pirfenidone Product Table 152. Glenmark Pharmaceuticals Recent Development Table 153. Koye Pharmaceuticals Corporation Information Table 154. Koye Pharmaceuticals Introduction and Business Overview Table 155. Koye Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 156. Koye Pharmaceuticals Pirfenidone Product Table 157. Koye Pharmaceuticals Recent Development Table 158. MSN Laboratories Corporation Information Table 159. MSN Laboratories Introduction and Business Overview Table 160. MSN Laboratories Pirfenidone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 161. MSN Laboratories Pirfenidone Product Table 162. MSN Laboratories Recent Development Table 163. Wockhardt Corporation Information Table 164. Wockhardt Introduction and Business Overview Table 165. Wockhardt Pirfenidone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 166. Wockhardt Pirfenidone Product Table 167. Wockhardt Recent Development Table 168. Incepta Pharmaceuticals Corporation Information Table 169. Incepta Pharmaceuticals Introduction and Business Overview Table 170. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 171. Incepta Pharmaceuticals Pirfenidone Product Table 172. Incepta Pharmaceuticals Recent Development Table 173. Unimed Unihealth Corporation Information Table 174. Unimed Unihealth Introduction and Business Overview Table 175. Unimed Unihealth Pirfenidone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 176. Unimed Unihealth Pirfenidone Product Table 177. Unimed Unihealth Recent Development Table 178. Key Raw Materials Lists Table 179. Raw Materials Key Suppliers Lists Table 180. Pirfenidone Market Trends Table 181. Pirfenidone Market Drivers Table 182. Pirfenidone Market Challenges Table 183. Pirfenidone Market Restraints Table 184. Pirfenidone Distributors List Table 185. Pirfenidone Downstream Customers Table 186. Research Programs/Design for This Report Table 187. Key Data Information from Secondary Sources Table 188. Key Data Information from Primary Sources List of Figures Figure 1. Pirfenidone Product Picture Figure 2. Global Pirfenidone Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Pirfenidone Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Pirfenidone Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of Tablet Figure 6. Global Tablet Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of Capsule Figure 8. Global Capsule Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Product Picture of Other Figure 10. Global Other Sales YoY Growth (2016-2021) & (K Pcs) Figure 11. Global Pirfenidone Sales by Type (2016-2027) & (US$ Million) Figure 12. Global Pirfenidone Sales Market Share in Volume by Type (2016-2021) Figure 13. Global Pirfenidone Sales Market Share in Value by Type (2016-2021) Figure 14. Global Pirfenidone Sales Market Share in Volume by Type (2022-2027) Figure 15. Global Pirfenidone Sales Market Share in Value by Type (2022-2027) Figure 16. North America Pirfenidone Sales Market Share in Volume by Type in 2020 Figure 17. North America Pirfenidone Sales Market Share in Value by Type in 2020 Figure 18. Europe Pirfenidone Sales Market Share in Volume by Type in 2020 Figure 19. Europe Pirfenidone Sales Market Share in Value by Type in 2020 Figure 20. Asia-Pacific Pirfenidone Sales Market Share in Volume by Type in 2020 Figure 21. Asia-Pacific Pirfenidone Sales Market Share in Value by Type in 2020 Figure 22. Latin America Pirfenidone Sales Market Share in Volume by Type in 2020 Figure 23. Latin America Pirfenidone Sales Market Share in Value by Type in 2020 Figure 24. Middle East and Africa Pirfenidone Sales Market Share in Volume by Type in 2020 Figure 25. Middle East and Africa Pirfenidone Sales Market Share in Value by Type in 2020 Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Pirfenidone Sales in 2020 Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Pirfenidone Revenue in 2020 Figure 28. Pirfenidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 29. Product Picture of Mild Idiopathic Pulmonary Fibrosis Figure 30. Global Mild Idiopathic Pulmonary Fibrosis Sales YoY Growth (2016-2027) & (K Pcs) Figure 31. Product Picture of Moderate Idiopathic Pulmonary Fibrosis Figure 32. Global Moderate Idiopathic Pulmonary Fibrosis Sales YoY Growth (2016-2027) & (K Pcs) Figure 33. Product Picture of Other Figure 34. Global Other Sales YoY Growth (2016-2027) & (K Pcs) Figure 35. Global Pirfenidone Sales by Application (2016-2027) & (US$ Million) Figure 36. Global Pirfenidone Sales Market Share in Volume by Application (2016-2021) Figure 37. Global Pirfenidone Sales Market Share in Value by Application (2016-2021) Figure 38. Global Pirfenidone Sales Market Share in Volume by Application (2022-2027) Figure 39. North America Pirfenidone Sales Market Share in Volume by Application in 2020 Figure 40. Latin America Pirfenidone Sales Market Share in Value by Application in 2020 Figure 41. Middle East and Africa Pirfenidone Sales Market Share in Value by Application in 2020 Figure 42. Key Raw Materials Price Figure 43. Pirfenidone Manufacturing Cost Structure Figure 44. Pirfenidone Industrial Chain Analysis Figure 45. Channels of Distribution Figure 46. Distributors Profiles Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

Genentech (Roche) Shionogi GNI Group Beijing Continent Cipla Lupin Ltd Zydus Cadila Glenmark Pharmaceuticals Koye Pharmaceuticals MSN Laboratories Wockhardt Incepta Pharmaceuticals Unimed Unihealth